Will Johnson & Johnson Raise Its Dividend in 2018?
Just about everyone has some products from Johnson & Johnson (NYSE: JNJ) in their medicine cabinets, ranging from over-the-counter medicines like Tylenol and Benadryl to Band-Aid bandages. Yet what has driven Johnson & Johnson's growth lately -- both in its overall sales and in the dividends it pays to its shareholders -- has been the healthcare giant's pharmaceutical business.
With decades of dividend growth under its belt, Johnson & Johnson has given its investors reason to expect regular dividend increases each and every year. But are there any challenges that J&J faces right now that could jeopardize that long streak of rising payouts in 2018? Let's take a closer look to see what dividend investors should look for from Johnson & Johnson in the year to come.
Image source: Johnson & Johnson.
Source: Fool.com
Johnson & Johnson Stock
The stock is one of the favorites of our community with 41 Buy predictions and 1 Sell predictions.
With a target price of 192 € there is a positive potential of 31.83% for Johnson & Johnson compared to the current price of 145.64 €.
